Pressure BioSciences, Inc. (PBIO)
OTCMKTS: PBIO · Delayed Price · USD
0.227
+0.007 (3.09%)
Apr 26, 2024, 10:21 AM EDT - Market open

Company Description

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia.

The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.

It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3.

The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents.

The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions.

It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center.

The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014.

The company was incorporated in 1978 and is based in South Easton, Massachusetts.

Pressure BioSciences, Inc.
Country MA
Founded 1978
IPO Date Oct 31, 1996
Industry Medical Devices
Sector Healthcare
Employees 16
CEO Richard T. Schumacher

Contact Details

Address:
480 Neponset St.
Canton, Massachusetts 02021
United States
Phone 5082301828
Website pressurebiosciences.com

Stock Details

Ticker Symbol PBIO
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000830656
CUSIP Number 74112E208
ISIN Number US74112E2081
Employer ID 04-2652826
SIC Code 3826

Key Executives

Name Position
Richard T. Schumacher Founder, President, Chief Executive Officer, Treasurer, Interim Chief Financial Officer, Clerk and Director
Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. Senior Vice President of Engineering
Dr. Alexander V. Lazarev Ph.D. Vice President of Research and Development
John B. Hollister Director of Sales and Marketing

Latest SEC Filings

Date Type Title
Apr 22, 2024 8-K Current Report
Apr 1, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Feb 27, 2024 DEF 14A Other definitive proxy statements
Jan 25, 2024 8-K Current Report
Nov 20, 2023 10-Q Quarterly Report
Nov 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Oct 24, 2023 8-K Current Report
Aug 21, 2023 10-Q Quarterly Report
Aug 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
May 15, 2023 10-Q Quarterly Report